KIORA PHARMACEUTICALS, INC. Increase (Decrease) in Other Receivables
KIORA PHARMACEUTICALS, INC. (KPRX) reported Increase (Decrease) in Other Receivables of $144.31 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$91.34K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $235.65K, a 46.82% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2025-06-30 was -$46.61K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was $443.12K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2018 was $0.00.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2017 was -$37.35K.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2016 was -$3.23M, a 456.32% decline from fiscal 2015.
- KIORA PHARMACEUTICALS, INC. increase (decrease) in other receivables for fiscal 2015 was $907.50K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$91.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $144.31K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $235.65K 10-Q · filed 2026-05-08 | |||
| 2025-06-30 | -$46.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $396.51K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $443.12K 10-Q · filed 2026-05-08 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $0.00 derived: sum of 3 quarters · filed 2019-03-01 | $0.00 10-K · filed 2019-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-13 | $0.00 10-Q · filed 2018-11-13 | -$602.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | -$602.00K derived: sum of 3 quarters · filed 2019-03-01 | -$146.08K derived: sum of 4 quarters · filed 2019-03-01 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | -$602.00K derived: sum of 2 quarters · filed 2019-03-01 | -$146.08K derived: sum of 3 quarters · filed 2019-03-01 | $3.89M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-12-31 | -$602.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$146.08K derived: sum of 2 quarters · filed 2019-03-01 | $3.89M derived: sum of 3 quarters · filed 2019-03-01 | -$37.35K 10-K · filed 2019-03-01 |
| 2017-09-30 | $455.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $4.49M derived: sum of 2 quarters · filed 2018-11-13 | $564.65K 10-Q · filed 2018-11-13 | -$290.35K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $108.73K 10-Q · filed 2018-08-03 | -$746.27K derived: sum of 3 quarters · filed 2018-08-03 | -$2.26M derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | -$3.93M 10-Q · filed 2018-05-11 | -$4.78M derived: sum of 2 quarters · filed 2018-05-11 | -$6.30M derived: sum of 3 quarters · filed 2018-05-11 | -$6.59M derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | -$855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | -$2.37M derived: sum of 2 quarters · filed 2018-03-02 | -$2.66M derived: sum of 3 quarters · filed 2018-03-02 | -$3.23M 10-K · filed 2018-03-02 |
| 2016-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.81M derived: sum of 2 quarters · filed 2017-11-14 | -$2.38M 10-Q · filed 2017-11-14 | -$471.13K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$291.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$861.52K 10-Q · filed 2017-08-04 | $1.05M derived: sum of 3 quarters · filed 2017-08-04 | $45.98K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | -$570.00K 10-Q · filed 2017-05-05 | $1.34M derived: sum of 2 quarters · filed 2017-05-05 | $337.50K derived: sum of 3 quarters · filed 2017-05-05 | $337.50K derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $907.50K derived: sum of 2 quarters · filed 2017-02-23 | $907.50K derived: sum of 3 quarters · filed 2017-02-23 | $907.50K 10-K · filed 2017-02-23 |
| 2015-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | -$1.00M derived: sum of 2 quarters · filed 2016-11-01 | -$1.00M 10-Q · filed 2016-11-01 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |